Daiken Medical Co., Ltd. (TYO:7775)

Japan flag Japan · Delayed Price · Currency is JPY
421.00
+1.00 (0.24%)
Aug 5, 2026, 3:30 PM JST
Market Cap12.09B -4.5%
Revenue (ttm)10.23B +1.8%
Net Income873.49M -14.7%
EPS30.40 -14.7%
Shares Out 28.73M
PE Ratio13.85
Forward PEn/a
Dividend20.00 (4.76%)
Ex-Dividend DateSep 29, 2026
Volume24,300
Open420.00
Previous Close420.00
Day's Range418.00 - 421.00
52-Week Range409.00 - 489.00
Beta0.10
Analystsn/a
Price Targetn/a
Earnings DateJul 31, 2026

About Daiken Medical

Daiken Medical Co., Ltd. engages in the planning, development, manufacturing, and sales of anesthesia-related and hospital infection prevention products in Japan and internationally. The company offers suction devices and PCA device; balloon type projector and syringe injector disposable infusion pumps; double lumen bronchial tube and disposable pulp system; syringe pump; handwashing water system and dispenser; wiper towel; and breath warm, sterimatt, and wet disinfectant mats. It is also involved in manufacture, sale, and trading of medical eq... [Read more]

Sector Healthcare
Founded 1968
Employees 185
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 7775
Full Company Profile

Financial Performance

In fiscal year 2026, Daiken Medical's revenue was 10.29 billion, an increase of 3.41% compared to the previous year's 9.95 billion. Earnings were 922.00 million, a decrease of -15.95%.

Financial Statements

News

Elastomeric Infusion Pumps Market worth $1.49 billion by 2030 at 5.3%, says MarketsandMarkets™

Delray Beach, FL, Jan. 29, 2026 (GLOBE NEWSWIRE) -- In terms of value, the Elastomeric Infusion Pumps Market is expected to reach USD 1.49 billion by 2030 from USD 1.15 billion in 2025, at a CAGR of 5...

6 months ago - Benzinga

Elastomeric Infusion Pumps Market worth $1.49 billion by 2030, at a CAGR of 5.3%, says MarketsandMarkets™

Delray Beach, FL, Nov. 28, 2025 (GLOBE NEWSWIRE) -- The Elastomeric Infusion Pumps Market is expected to reach USD 1.49 billion by 2030 from USD 1.15 billion in 2025, at a CAGR of 5.3% during the fore...

8 months ago - Benzinga